97 related articles for article (PubMed ID: 22204167)
21. Medicare Part D: selected issues for plan sponsors, pharmacists, and beneficiaries in 2009.
Stubbings J; DePue RJ
Am J Manag Care; 2009 Sep; 15(9):645-9. PubMed ID: 19747029
[TBL] [Abstract][Full Text] [Related]
22. Factors associated with independent pharmacy owners' satisfaction with Medicare Part D contracts.
Zhang S; Doucette WR; Urmie JM; Xie Y; Brooks JM
Res Social Adm Pharm; 2010 Jun; 6(2):121-9. PubMed ID: 20511111
[TBL] [Abstract][Full Text] [Related]
23. Providing medications for low-income and indigent patients: success for Medicare Part D walks in the back door.
Flaer PJ; Younis MZ; Malow RM
J Health Care Finance; 2008; 34(3):1-5. PubMed ID: 18468374
[TBL] [Abstract][Full Text] [Related]
24. Continuing effects of Medicare Part D on rural independent pharmacies who are the sole retail provider in their community.
Radford A; Mason M; Richardson I; Rutledge S; Poley S; Mueller K; Slifkin R
Res Social Adm Pharm; 2009 Mar; 5(1):17-30. PubMed ID: 19285286
[TBL] [Abstract][Full Text] [Related]
25. Chronic kidney disease and medicare.
St Peter WL
J Manag Care Pharm; 2007 Dec; 13(9 Suppl D):S13-8. PubMed ID: 18177214
[TBL] [Abstract][Full Text] [Related]
26. Medicare Part D in 2008: rising prices and growing confusion.
Flaer PJ; Younis MZ; Hussain AA; Malow RM
J Health Care Finance; 2008; 34(4):89-92. PubMed ID: 21110483
[TBL] [Abstract][Full Text] [Related]
27. L-carnitine use in dialysis patients: is national coverage for supplementation justified? What were CMS regulators thinking--or were they?
Steinman TI; Nissenson AR; Glassock RJ; Dickmeyer J; Mattern WD; Parker TF; Hull AR
Nephrol News Issues; 2003 Apr; 17(5):28-30, 32-4, 36 passim. PubMed ID: 12715624
[TBL] [Abstract][Full Text] [Related]
28. Why all prescribed medications are not taken: results from a survey of chronic dialysis patients.
Holley JL; DeVore CC
Adv Perit Dial; 2006; 22():162-6. PubMed ID: 16983962
[TBL] [Abstract][Full Text] [Related]
29. Adverse selection in the Medicare prescription drug program.
Riley GF; Levy JM; Montgomery MA
Health Aff (Millwood); 2009; 28(6):1826-37. PubMed ID: 19887424
[TBL] [Abstract][Full Text] [Related]
30. The impact of Medicare Part D on prescription drug use by the elderly.
Lichtenberg FR; Sun SX
Health Aff (Millwood); 2007; 26(6):1735-44. PubMed ID: 17978393
[TBL] [Abstract][Full Text] [Related]
31. Pharmaceuticals and medical devices: Medicare Part D. End-of-year issue brief.
Chaps NA
Issue Brief Health Policy Track Serv; 2009 Jan; ():1-26. PubMed ID: 19301435
[No Abstract] [Full Text] [Related]
32. How the doughnut hole affects prescription fulfillment decisions involving cardiovascular medications for Medicare Part D enrollees.
Hales JW; George S
Manag Care; 2010 Dec; 19(12):36-44. PubMed ID: 21291131
[TBL] [Abstract][Full Text] [Related]
33. Why using current medications to select a medicare Part D plan may lead to higher out-of-pocket payments.
Domino ME; Stearns SC; Norton EC; Yeh WS
Med Care Res Rev; 2008 Feb; 65(1):114-26. PubMed ID: 17942795
[TBL] [Abstract][Full Text] [Related]
34. Medicare Part D--the sea of choices meets the donut hole.
Flaer PJ; Dondériz A; Younis MZ
J Health Care Finance; 2007; 34(1):1-7. PubMed ID: 18972980
[TBL] [Abstract][Full Text] [Related]
35. Medicare-approved drug discount cards and renal transplant patients: how much can these cards reduce prescription costs?
Chisholm MA; Marshall J; Smith KE; Garrett CJ; Turner JC
Clin Transplant; 2005 Jun; 19(3):357-63. PubMed ID: 15877798
[TBL] [Abstract][Full Text] [Related]
36. Medicare Part D policy update and implications for 2010.
DePue RJ; Stubbings J; Baker DC
Am J Manag Care; 2010 May; 16(5):e117-20. PubMed ID: 20455637
[TBL] [Abstract][Full Text] [Related]
37. Impact of Medicare Part D on seniors' out-of-pocket expenditures on medications.
Millett C; Everett CJ; Matheson EM; Bindman AB; Mainous AG
Arch Intern Med; 2010 Aug; 170(15):1325-30. PubMed ID: 20696956
[TBL] [Abstract][Full Text] [Related]
38. Navigating Medicare drug coverage: Part B vs. Part D.
Piper KB
Manag Care; 2006 Jul; 15(7 Suppl 3):17-20. PubMed ID: 16898056
[TBL] [Abstract][Full Text] [Related]
39. Analysis of national annual variation in total patient out-of-pocket Medicare Part D stand-alone prescription drug plan costs from 2007 to 2008.
Walberg MP; Patel RA; Amaral MM
J Med Econ; 2008; 11(4):625-37. PubMed ID: 19450072
[TBL] [Abstract][Full Text] [Related]
40. Medicare prescription drug coverage (part D): challenges and opportunities.
Witten B
Nephrol News Issues; 2006 Aug; 20(9):14-6, 18. PubMed ID: 16916055
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
